-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMIX BIOPHARMA, - NEXICART-2 FINAL READOUT AND BLA SUBMISSION PLANNED FOR MID-2027

Reuters·09/29/2026 11:00:50

Please log in to view news